TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
42 hedge funds and large institutions have $6.59M invested in Tvardi Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-27
Holders Change %
-39.13%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
18
Closed
32
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$4K
Top Buyers
1 |
Rockefeller Capital Management
New York
|
+$953K |
2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$656K |
3 |
SC
Shay Capital
New York
|
+$524K |
4 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
+$277K |
5 |
UBS Group
Zurich,
Switzerland
|
+$48.5K |